Global MRSA Drugs Market Research Report 2023-2032 Featuring AbbVie, Basilea Pharmaceutica, Crystal Genomics, Cumberland Pharmaceuticals, Melinta Therapeutics, Paratek Pharmaceuticals, and Pfizer
The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has...
PR NewswireMar 28 10:15 ET
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 7 11:52 ET
Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 Loss per Share (Vs US$0.38 Loss in FY 2022)
Yahoo FinanceMar 7 05:20 ET
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q4 2023 Earnings Conference
The following is a summary of the Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript:Financial Performance:Cumberland Pharmaceuticals reported Q4 net revenue of $9.4 million, obse
moomoo AIMar 5 22:44 ET · Conference Call
Cumberland Pharma 4Q Rev $9.35M >CPIX
Cumberland Pharma 4Q Rev $9.35M >CPIX
Dow JonesMar 5 16:16 ET
Express News | Cumberland Pharmaceuticals Q4 2023 Adj. EPS $(0.11) Down From $(0.05) YoY; Revenue $9.353M Up From $9.123M Est
Moomoo 24/7Mar 5 16:14 ET
Cumberland Pharmaceuticals Non-GAAP EPS of $0.17, Revenue of $40M
Seeking AlphaMar 5 16:13 ET
Press Release: Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results PR Newswire NASHVILLE, Tenn., March 5, 2024 2023 highlights include expanded FDA approval and new study publications NASHVILLE, Ten
Dow JonesMar 5 16:05 ET
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. • Target (NYSE:TGT) is estimated to report quarterly earnings
BenzingaMar 5 05:00 ET
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
NASHVILLE, Tenn., Feb. 27, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2023 financial res
PR NewswireFeb 27 16:05 ET
Cumberland Pharmaceuticals Files for $100M Mixed Shelf
Seeking AlphaDec 14, 2023 17:28 ET
Trending Industry Today: Canopy Growth Leads Losses In Cannabis Stocks
December 11th - The industry of $Cannabis(BK2997.US)$ is trending down in regular trading hours with 4 constituents up, 16 constituents down and Canopy Growth leading Losses.$Canopy Growth(CGC.US)$ sl
moomoo NewsDec 11, 2023 15:40 ET
Cumberland Pharmaceuticals Non-GAAP EPS of $0.02, Revenue of $10.1M
Seeking AlphaNov 7, 2023 16:43 ET
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 EPS $0.02
04:11 PM EST, 11/07/2023 (MT Newswires) -- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 EPS $0.02
MT NewswiresNov 7, 2023 16:11 ET
Press Release: Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results PR Newswire NASHVILLE, Tenn., Nov. 7, 2023 NASHVILLE, Tenn., Nov. 7, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NA
Dow JonesNov 7, 2023 16:05 ET
Cumberland Pharma 3Q Loss/Shr 7c >CPIX
Cumberland Pharma 3Q Loss/Shr 7c >CPIX
Dow JonesNov 7, 2023 16:05 ET
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the third quarter 2023...
PR NewswireOct 31, 2023 16:05 ET
NEW VIBATV PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
NASHVILLE, Tenn., Oct. 10, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today a new publication in Antimicrobial Agents and Chemotherapy1 detailing the results of the first clinical study
PR NewswireOct 10, 2023 16:05 ET
Correction to SEC Fines Article
The regulator filed an order against Nicole Fernandez-McGovern, the chief financial officer of AgEagle Aerial Systems, over alleged individual reporting failures. "SEC Fines 5 Public Companies, Inside
Dow JonesSep 27, 2023 10:25 ET
SEC Fines 5 Public Companies, Insiders Over Reporting Failures
By Dean Seal The U.S. Securities and Exchange Commission has fined five public companies and six corporate insiders over failures to report information about stock holdings and trading. The Wall Str
Dow JonesSep 27, 2023 10:13 ET
No Data
No Data